SFN promotes renal fibrosis via binding with MYH9 in chronic kidney disease
Authors:
Open Access
- 9 July 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 979, 176806
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82300841)
This publication has 36 references indexed in Scilit:
- Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosisEuropean Journal of Pharmacology, 2022
- Redox signaling pathways in unilateral ureteral obstruction (UUO)-induced renal fibrosisFree Radical Biology and Medicine, 2021
- Downregulation of 14-3-3 Proteins in Alzheimer’s DiseaseMolecular Neurobiology, 2019
- TGF-β/Smad and Renal Fibrosis2019
- Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016JAMA Network Open, 2018
- MYH9: Structure, functions and role of non-muscle myosin IIA in human diseaseGene, 2018
- TGF-β1/p53 signaling in renal fibrogenesisCellular Signalling, 2018
- AKI on CKD: heightened injury, suppressed repair, and the underlying mechanismsKidney International, 2017
- The role of the 14-3-3 protein family in health, disease, and drug developmentDrug Discovery Today, 2016
- The molecular mechanism and potential role of heat shock-induced p53 protein accumulationMolecular and Cellular Biochemistry, 2013